- Activities
- Uveal Melanoma Guideline
Uveal Melanoma Guideline
The Uveal Melanoma Guideline is currently being updated under the chairmanship of Dr Paul Nathan.
These Guidelines will be developed in accordance with the Melanoma Focus Guideline Development Methodology Manual. The methods have been accredited by NICE as complying with their AGREE II criteria for the rigorous development of evidence-based guidelines.
“Uveal melanoma is now classified as a distinct disease entity (rather than a different form of cutaneous melanoma) and has been granted ‘orphan status’ which means that there are some incentives to encourage new medicines to be developed. It is an exciting time for uveal melanoma as there are new treatments in development which will hopefully be available outside of clinical trials soon.”
Dr Paul Nathan, Trustee (consultant medical oncologist, Mount Vernon Cancer Centre)
Background
There is a need for a specialist guideline on uveal (ocular) melanoma as this form of the disease is a very rare condition which is managed differently from other melanomas. Comprehensive guidance on this subject was developed for the first time in 2015. While much of the guideline is still current, the following sections are being updated or added:
- molecular pathology and features
- prognostic markers
- loco-regional management of hepatic predominant disease
- management of metastatic disease
- adjuvant radiation therapy
- support of patients
Members of the Uveal Melanoma Guideline Development Group:
- Dr Paul Nathan Chairman Medical Oncologist
- Prof Sarah Coupland Pathologist
- Dr Rachel Lewis Clinical Oncologist
- Dr Sachin Modi Interventional Radiologist
- Dr Sukaina Rashid Medical Oncologist
- Dr Joe Sacco Medical oncologist
- Dr Karen Sisley Senior Lecturer
- Dr Samra Turajlic Medical Oncologist
- Dr Matthew Wheater Medical Oncologist
- Ms Audrey Woraker Patient Representative
- Ms Nancy Turnbull, Project Manager
Note: The Uveal Melanoma Guideline is currently being updated under the chairmanship of Dr Paul Nathan. Any queries about this process should be directed to info@melanomafocus.com.
The original guideline has been published in The European Journal of Cancer (EJC) (Eur J Cancer 2015 Nov;51(16):2404-12) with open access. Follow this link for the PubMed abstract.
Click here for the original guideline
- Press Release: Melanoma Focus—-
- News Article by NICE: ‘NICE grants seal of approval to guidelines on rare form of cancer’
- Uveal Melanoma National Guideline Report Summary
- Lay Summary of information for patients, carers and public
- Resources Page: Full Report & supporting documents
|
Dr Miss Professor Ms Professor Dr Radiologist Mr Professor Dr Dr Dr Mr Professor Mr Mr Mr Dr Radiologist Dr Ms |
Paul Victoria Sarah Kathryn Bertil Jonathan Stephen Paula Lesley Olivia Ernie Kieran Christian Neil Ian Sachin Brian Peter Nancy |
Nathan Cohen Coupland Curtis Damato Evans Fenwick Ghaneh Kirkpatrick Li Marshall McGuirk Ottensmeier Pearce Rennie Salvi Stedman Szlosarek Turnbull |
Medical Oncologist Ophthalmic Surgeon Pathologist Patient Representative Ophthalmic Surgeon Interventional Hepatic Surgeon Surgeon Patient Representative Methodologist Medical Oncologist Patient Representative Medical Oncologist Hepatic Surgeon Ophthalmic Surgeon Ophthalmic Surgeon Interventional Medical Oncologist Project Manager |
Melanoma patients invited to focus group
We are currently developing our Patient Decision Aid and would like to invite melanoma patients to take part in a focus group (online format) to help us improve this service.
READ MORENew staff at Melanoma Focus
Following Simon Rodwell’s retirement, Susanna Daniels has taken over as CEO. We are also joined by a new Fundraising Manager, Fiona Prakasam, and Social Media & Digital Officer, Jen Rush.
READ MOREHead & Neck Mucosal Melanoma Guideline accepted for publication
A paper based on this guideline is to be published by the European Journal of Cancer. This is the product of two years’ deliberations and research by a group of clinicians, nurses and patient representatives led by Professor Kevin Harrington and funded by Melanoma Focus. Follow the link for further details and the final documents.
READ MORE
Hackney Half Marathon 2021
Join Team Melanoma for the Hackney Half Marathon 2021 Event Details: Sunday 26th September 2021 Hackney, London 13.1 miles £100 minimum sponsorship On Sunday 26 September 2021, be part of the electric atmosphere of the Hackney Half Marathon. The half marathon showcases the best of Hackney through the fast and flat city streets. Take in […]
READ MORE
Royal Parks Half Marathon 2021
Join Team Melanoma for the Royal Parks Half Marathon 2021 Event Details: Sunday 10th October 2021 Hyde Park, London 13.1 miles £350 minimum sponsorship The Royal Parks Half Marathon is one of the capital’s most scenic running events and welcomes thousands of runners every year. This stunning central London Half Marathon takes in some of […]
READ MORE
Focus on Melanoma Virtual Meeting
We are delighted to announce that registration is now open for this year’s Focus on Melanoma Virtual Regional Meeting. The event is organised by Dr. Andrew Furness, The Royal Marsden Hospital CME points will be applied from the Federation of the Royal Colleges of Physicians of the United Kingdom (RCP UK), the Royal College of […]
READ MORE